Limoges Cedex 1, France Clinical Trials

A listing of Limoges Cedex 1, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 43 clinical trials
Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults

Introduction: Sarcomas are rare tumors of connective tissue. The exact overall incidence of sarcomas is unknown due to diagnostic difficulties and the various histological subtypes (over 80 subtypes). However, the apparent increasing incidence of sarcomas suggests environmental causes such as pesticides. Except for some specific factors (i.e. ionizing radiation, vinyl …

 (163.8 away) Contact site
  • 13 May, 2019
  • +8 other locations
Safety and Efficacy of Silk Vista and Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment

The FIRST study is an observational, prospective, multi-center, international, single-arm, study. The aim of the study is to collect safety and efficacy information on the use of the silk vista and silk vista baby flow diverter in order to assess clinical safety and performance of the device for treating intracranial …

intracranial aneurysm
ruptured aneurysm
multiple aneurysms
Chu Dupuytren Limoges
 (1.2 away) Contact site
  • 25 Nov, 2020
  • +24 other locations
Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France

On January 2020, the discovery of a new coronavirus (SARS-CoV-2) was officially announced by the Chinese health authorities and the World Health Organization (WHO). Its complete genome was sequenced by the laboratory of respiratory infection viruses at the Institut Pasteur on 29 January 2020 in France. This will allow the …

serologic tests
coronavirus infection
serologic test
CHU Poitiers
 (67.6 away) Contact site
  • 21 Sep, 2020
  • +26 other locations
Serum Neurofilament-light Chain Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

The investigators hypothesize that serum neurofilament-light chain (NfL) levels can provide information about the level of activity and progression of Multiple Sclerosis at different stages and landmarks of the disease.

CHU de Potiers
 (67.6 away) Contact site
  • 19 Aug, 2020
  • +22 other locations
Early Identification of SEPsis SIGNs in Emergency Department

Objective of SepSIGN project is to validate biomarkers able to predict the clinical worsening of patients freshly admitted at Emergency Department. Targeted population is adult patients, freshly admitted at ED, with a suspected or confirmed infection.

systemic inflammatory response syndrome
inflammatory response
CHU Dupuytren
 (1.2 away) Contact site
  • 30 Sep, 2020
  • +9 other locations
Biomarkers in Parkinsonian Syndromes

Parkinson disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are neurodegenerative disorders. PD and MSA are alpha-synucleinopathies, which are characterized by the abnormal accumulation of alpha-synuclein, while tau protein accumulates in PSP. The development of biological markers for the diagnosis and prognosis in PD, MSA and PSP …

neurodegenerative disorders
tau protein
abnormal protein
CHU de Limoges
 (1.2 away) Contact site
  • 15 Apr, 2020
  • +2 other locations
IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

Regarding Tofacitinib, newly introduced on the market, few data on drug retention and no data on the factors predictive of Tofacitinib drug survival in patients with RA are available. Therefore, the primary objective of the DeFacTo study will be to identify the factors predictive of Tofacitinib drug survival in patients …

Cabinet Medical
 (2.4 away) Contact site
  • 12 Oct, 2020
  • +60 other locations
Comparison Thymoglobulin and Grafalon

This is a prospective, multicenter, observational, non -interventional study with comparison with an historical cohort Investigators will compare the efficacy and safety of Thymoglobulin (Sanofi-Aventis) versus Grafalon (Neovii, previously ATG-Fresenius) in renal transplantation by evaluating patient survival, graft survival, delayed graft function, acute rejection, DSA occurrence and toxicities, various infections …

delayed graft function
CHU Dupuytren 2
 (1.2 away) Contact site
  • 12 Jul, 2020
  • +13 other locations
Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

This study aims analyze the transcriptome to identify predictive biomarkers of IVIG in CIDP patients. 25 patients with a diagnosis of CIDP according to European criteria, nave of treatment, will be included and followed for 1 year. Clinical assessment (RT-MRC ; Martin vigorimeter, RT-mISS,R-ODS,TW25, 9hole-peg test) will be performed at …

immune globulin
CHU de Poitiers
 (65.1 away) Contact site
  • 07 Jun, 2020
  • +20 other locations
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

Hypopituitary adults with all the hormonal deficiencies are well subsituted excepted for the growth hormone (GH) and died earlier than the rest of the population. GH deficiency involves a fat mass increase with regard to lean mass, an atherogenic lipidic profile and participating to osteopenia mechanism and decrease the life …

growth hormone treatment
GH deficiency
thyroid hormones
hormone therapy
UH of Tours
 (110.8 away) Contact site
  • 07 Nov, 2020
  • +5 other locations